Cost Effectiveness of Roxithromycin Versus Cefaclor in Australia
- 期刊名称PharmacoEconomics
- 作者W. Guy Scott,Bruce C. Cooper,Helen M. Scott,Murray W. Tilyard…
- 卷第7卷
- 期第1期
- 印刷ISSN1170-7690
- 电子ISSN1179-2027
- 文件大小258.74KB
- 发表时间1995-01
- DOI10.2165/00019053-199507010-00009
- 页码93-94
Cost studies in clinical trialsShaya, Fadia T; Samant, Navendu · Expert Review of Pharmacoeconomics & Outcomes Research · 2004
Pharmacoeconomics of etravirineFullerton, DS; Watson, Mary Jane; Anderson, David; Witek, James; Martin, Silas C; Mrus, Joseph M · Expert Review of Pharmacoeconomics & Outcomes Research · 2010
Multi-Attribute Preference FunctionsTorrance, George W.; Furlong, William; Feeny, David; Boyle, Michael · PharmacoEconomics · 1995
Dabigatran EtexilateMcKeage, Kate · PharmacoEconomics · 2012
Sickle Cell AnaemiaNietert, Paul J.; Silverstein, Marc D.; Abboud, Miguel R. · PharmacoEconomics · 2002
Analysis Sans FrontièresSculpher, Mark J; Drummond, Michael F · PharmacoEconomics · 2006
Pharmaceutical Risk-Sharing AgreementsCook, Joseph P; Vernon, John A; Manning, Richard · PharmacoEconomics · 2008
Pharmacoeconomics in the New MillenniumThwaites, Rob; Townsend, Raymond J. · PharmacoEconomics · 1998